EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Surgical Management of Desmoid Tumors—Patient Selection, Timing, and Approach

Catherine Sarre Lazcano, Alessandro Gronchi iD

Current Oncology · 18.07.2025 · 32 (7) · 408

DOI: 10.3390/curroncol32070408 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 18.07.2025. Verfasst von Catherine Sarre Lazcano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada. Hauptthemen laut MEDLINE: Desmoid Tumors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Desmoid tumors are rare, deep-seated myofibroblastic tumors with an unpredictable course, ranging from spontaneous regression to infiltrative growth and locally aggressive behavior, but without metastatic potential. Over the past few decades, advances in understanding their natural history, underlying molecular pathways, and patient care priorities have shifted the treatment paradigm from upfront surgical resection to initial active surveillance, with further treatment dictated by continuous disease progression or associated symptoms. However, there are still specific scenarios where surgery continues to play an important role in locoregional treatment and symptom control. This article will focus on current treatment strategies and surgical indications in adult patients with desmoid tumors, emphasizing patient selection, anatomic site-specific considerations, and surgical technique. Understanding the nuanced role of surgery within the growing treatment landscape is key for individualized patient care in a multidisciplinary setting to optimize quality of life and long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desmoid TumorsHumansPatient Selection

Stichwörter der Autor:innen

aggressive fibromatosisdesmoid tumorfunctional outcomesmarginssurgery

Autor:innen und Institutionen

  • Division of Surgical Oncology, Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

ORCID-Profile: Alessandro Gronchi

Zitieren

APA

Lazcano, C. S., & Gronchi, A. (2025). Surgical Management of Desmoid Tumors—Patient Selection, Timing, and Approach. Current Oncology, 32(7), 408. https://doi.org/10.3390/curroncol32070408

Vancouver

Lazcano CS, Gronchi A. Surgical Management of Desmoid Tumors—Patient Selection, Timing, and Approach. Current Oncology. 2025;32(7):408. doi:10.3390/curroncol32070408

BibTeX
@article{Lazcano2025,
  author = {Lazcano, Catherine Sarre and Gronchi, Alessandro},
  title = {Surgical Management of Desmoid Tumors—Patient Selection, Timing, and Approach},
  journal = {Current Oncology},
  year = {2025},
  volume = {32},
  number = {7},
  pages = {408},
  doi = {10.3390/curroncol32070408}
}
Kostenlos starten →